| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 09/29/2010 | CN101090887B Anthracene derivative, light emitting element using the same, and light emitting device using the same |
| 09/29/2010 | CN101027284B Novel crystalline form of (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)-piperazine-1-yl]-methanone hydrochloride |
| 09/29/2010 | CN101006076B Modulators of ATP-binding cassette transporters |
| 09/28/2010 | US7803944 Viral polymerase inhibitors |
| 09/28/2010 | US7803835 Substituted acetic acid derivatives |
| 09/28/2010 | US7803834 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof |
| 09/28/2010 | US7803833 (2R,5R)-2-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-7-methyl-1,7-diazaspiro[4.4]nonan-6-one or a pharmaceutically acceptable salt thereof; for treating diseases and conditions mediated by modulation of voltage-gated sodium channels; eating disorders, depression, epilepsy |
| 09/28/2010 | US7803811 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 09/28/2010 | CA2453881C 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives |
| 09/28/2010 | CA2415475C Pyrrolo[2,1-b][1,3]benzothiazepines and their use for the preparation of medicaments with antipsychotic activity |
| 09/28/2010 | CA2387016C Acrylamide derivatives as fab i inhibitors |
| 09/28/2010 | CA2382247C Azaindoles having serotonin receptor affinity |
| 09/23/2010 | WO2010107768A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
| 09/23/2010 | WO2010107029A1 Molecular probe precursor for pancreatic islet imaging and use of same |
| 09/23/2010 | WO2010106269A2 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics |
| 09/23/2010 | WO2010087419A3 Cyclopropanecarboxylic acid ester derivatives and their use as pest control agents |
| 09/23/2010 | WO2010083872A3 Materials for organic electroluminescence devices |
| 09/23/2010 | WO2010060070A3 Indolinone modulators of dopamine receptor |
| 09/23/2010 | US20100240909 process for the preparation of stable nitroxyl radicals |
| 09/23/2010 | US20100240908 Acetylene compound |
| 09/23/2010 | US20100240726 Compositions for treating amyloid associated diseases |
| 09/23/2010 | US20100240718 Novel heteroaryl-substituted acetone derivative, suitable for inhibiting phospholipase a2 |
| 09/23/2010 | US20100240678 Leukotriene b4 inhibitors |
| 09/23/2010 | US20100240656 Compounds as hsp90 inhibitors |
| 09/23/2010 | US20100240642 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators |
| 09/23/2010 | US20100240614 Indole Compounds Bearing Aryl or Heteroaryl Groups Having Sphingosine 1-Phosphate (S1P) Receptor Biological Activity |
| 09/23/2010 | CA2755526A1 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics |
| 09/23/2010 | CA2755253A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
| 09/22/2010 | EP2229935A1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 09/22/2010 | EP2229361A1 Tetrahydroindoles having sphingosine-1-phosphate receptor activity |
| 09/22/2010 | EP2229360A2 Indolinone derivatives and process for their manufacture |
| 09/22/2010 | EP2229359A1 Process for the manufacture of an indolinone derivative |
| 09/22/2010 | EP2229358A1 Indoles and their therapeutic use |
| 09/22/2010 | EP1799643B1 Indolone derivatives, processes for preparing them and their uses |
| 09/22/2010 | EP1620399B1 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 09/22/2010 | CN101842354A Catecholamine derivatives and prodrugs thereof |
| 09/22/2010 | CN101842353A 2, 3-substituted indole derivatives for treating viral infections |
| 09/22/2010 | CN101838271A Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| 09/22/2010 | CN101838264A Compound, optical film and process for producing optical film |
| 09/22/2010 | CN101838232A Preparation method for varespladib |
| 09/21/2010 | US7799933 4-{[1-(5-Chloro-2-methoxy-benzenesulfonyl)-1H-indole-6-carbonyl]-amino}-phenyl)-acetic acid; inhibiting liver carnitine palmitoyl transferase 1 |
| 09/21/2010 | US7799927 optical recording media with said organic dye as recording layer; high density Disk-Recordable (HD DVD-R) |
| 09/21/2010 | US7799819 chronic lymphocytic leukemia or acute lymphoblastic leukemia; use of specific compound (1R)-cyclopropanecarboxylic acid {2-[2-carbamoyl-1-(3-ethoxy-4-methoxy-phenyl)-ethyl]-7-chloro-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide |
| 09/21/2010 | US7799785 such as (4aS,13bR,14aR)-6-fluoro-1,4a,9,13b,14,14a-hexahydrodibenzo[3',4':6',7']-cyclohepta[1',2':4,5]pyrrolo[1,2-c]imidazole-3(2H)-thione, having binding affinities towards serotonin receptors, dopamine receptors and with norepinephrine reuptake inhibition properties; antidepressants; neuroleptic agents |
| 09/21/2010 | US7799524 methods of transferring a label from novel substrates to O6-alkylguanine-DNA alkyltransferases (AGT) and O6-alkylguanine-DNA alkyltransferase fusion proteins, and to novel substrates suitable in such methods |
| 09/21/2010 | CA2451573C Technical process for the manufacture of tropenol |
| 09/21/2010 | CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 09/21/2010 | CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them |
| 09/21/2010 | CA2428019C Estrogen receptor modulators |
| 09/21/2010 | CA2401502C Carboxylic acid derivatives as ip antagonists |
| 09/21/2010 | CA2379553C Process for phenylacetic acid derivatives |
| 09/16/2010 | WO2010104324A2 Halogenated isoindole compounds with superior binding affinity to beta-amyloid aggregates and fibrils, method for preparing same, and use thereof |
| 09/16/2010 | WO2010104093A1 Prophylactic or therapeutic agent for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivative or salt thereof as active ingredient |
| 09/16/2010 | WO2010103001A1 Tricyclic heterocyclic derivatives |
| 09/16/2010 | WO2010102758A2 Halogenalkylmethylenoxy-phenyl-substituted ketoenols |
| 09/16/2010 | WO2010102717A1 Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof |
| 09/16/2010 | WO2010102502A1 Carbazole oxime ester photoinitiator |
| 09/16/2010 | WO2010065865A3 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 09/16/2010 | WO2010057944A9 Dye conjugate imaging agents |
| 09/16/2010 | US20100234610 Method for producing optically active ester and method for producing optically active carboxylic acid |
| 09/16/2010 | US20100234350 Platelet adp receptor inhibitors |
| 09/16/2010 | US20100234307 Preparation and use of biphenyl amino acid derivatives for the treatment of obesity |
| 09/16/2010 | US20100234229 Substituted Spirocyclic Ketoenols |
| 09/16/2010 | US20100234221 Use of tetramic acid derivatives with fertilizers |
| 09/16/2010 | US20100233166 Novel ido inhibitors and methods of use |
| 09/16/2010 | DE102009012314A1 Oxo-heterocyclisch substituierte Alkylcarbonsäuren und ihre Verwendung Oxo-heterocyclic-substituted alkyl carboxylic acids and their use |
| 09/16/2010 | CA2755118A1 Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients |
| 09/16/2010 | CA2754847A1 Halogenalkylmethylenoxy-phenyl-substituted ketoenols |
| 09/16/2010 | CA2754542A1 Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof |
| 09/16/2010 | CA2749819A1 Tricyclic heterocyclic derivatives |
| 09/15/2010 | EP2079690B1 3-aza-bicyclo[3.1.0]hexane derivatives |
| 09/15/2010 | CN101835749A Substituted indoles |
| 09/15/2010 | CN101835748A Amino arylsulfonamide compounds and their use as 5-HT6 ligands field of invention |
| 09/15/2010 | CN101835747A Benzimidazole derivative |
| 09/15/2010 | CN101831486A Application of mycobacterium tuberculosis Rv1354c gene as medicament target |
| 09/15/2010 | CN101831289A Pyrene and fluorene copolymerized blue light materials with space structures |
| 09/15/2010 | CN101830854A Substituted phenylhydrazones compounds, preparation method and application thereof |
| 09/15/2010 | CN101830815A New cyclic compounds and method for preparing azepine spirocyclic compound by using same as intermediate |
| 09/14/2010 | US7795801 A light emission layer containing a partial carbazolyl structure and an adjacent hole blocking layer containing a styryl, borane, or carboline derivative; high emission intensity and efficiency; improved durability and heat resistance |
| 09/14/2010 | US7795471 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates |
| 09/14/2010 | US7795451 Powders; infrared radiation absorption; crystal structure; purity; stability |
| 09/14/2010 | US7795450 aministering N-(2,4-di-n-amylpentanoic acid amide)-tryptophanamide, for the treatment of diseases associated with the decreased binding of magnesium to the plasma membranes of their cells, such as hypertension, diabetes, non-insulin depepndent diabetes, pre-eclampsia and eclampsia |
| 09/14/2010 | US7795449 e.g.N,N',N''-triphenyl-N,N',N''-tris(9-phenylcarbazol-3-yl)-benzene-1,3,5-triamine; high glass transition point and excellent heat resistance |
| 09/14/2010 | US7795297 pharmaceutically acceptable addition salts of such compounds, pharmaceutical compositions containing such compounds, the process for their preparation, and their use as pharmacologically active substances, especially in the treatment of hypertriglyceridemia, hyperlipidemia, hypercholesterolemia, diabetes |
| 09/14/2010 | US7795296 Artificial sweenening for food, beverages |
| 09/14/2010 | US7795280 3-(2-Nitro-phenylsulfanyl)-1-pyridin-2-ylmethyl-1H-indole-6-carbonitrile, used for the treatment of benign prostate hyperplasia, bone disorders, female sexual dysfunction,, atherosclerosis, anemia, muscular atrophy, as contraceptives or for hormone replacement therapy |
| 09/14/2010 | US7795266 Tetrahydroindolone derivatives for treament of neurological conditions |
| 09/14/2010 | US7795250 Indole derivatives as antiviral agents |
| 09/14/2010 | CA2423691C Process for producing .gamma.-hydroxyamino acid derivatives and monatins |
| 09/14/2010 | CA2409715C .beta.-carboline derivatives useful as inhibitors of phosphodiesterase |
| 09/14/2010 | CA2394276C Serine protease inhibitors |
| 09/10/2010 | WO2010101882A1 Thermosetting ring-opening metathesis polymerization materials with thermally degradable linkages |
| 09/10/2010 | WO2010101127A1 Indole compound |
| 09/10/2010 | WO2010100475A1 Hydroxamic acid derivatives as gram-negative antibacterial agents |
| 09/10/2010 | WO2010100133A2 Indole derivatives for treating neurodegenerative diseases |
| 09/10/2010 | WO2010083441A3 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 09/10/2010 | CA2754283A1 Indole derivatives for treating neurodegenerative diseases |
| 09/09/2010 | US20100228025 Structured organic films having an added functionality |
| 09/09/2010 | US20100227906 C-substituted Diindolylmethane Compositions and Methods for the Treatment of Multiple Cancers |
| 09/09/2010 | US20100227894 Benzamide factor viia inhibitors useful as anticoagulants |